Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ARTL

Artelo Biosciences (ARTL)

Artelo Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARTL
DateTimeSourceHeadlineSymbolCompany
10/12/202401:15GlobeNewswire Inc.Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related AnorexiaNASDAQ:ARTLArtelo Biosciences Inc
19/11/202400:30GlobeNewswire Inc.Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit NASDAQ:ARTLArtelo Biosciences Inc
14/11/202400:30GlobeNewswire Inc.Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration SymposiumNASDAQ:ARTLArtelo Biosciences Inc
13/11/202400:00GlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
09/11/202408:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARTLArtelo Biosciences Inc
09/11/202408:30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ARTLArtelo Biosciences Inc
06/11/202400:30GlobeNewswire Inc.Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” ProgramNASDAQ:ARTLArtelo Biosciences Inc
10/10/202400:00GlobeNewswire Inc.Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16thNASDAQ:ARTLArtelo Biosciences Inc
04/09/202423:00GlobeNewswire Inc.Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ARTLArtelo Biosciences Inc
13/08/202422:00GlobeNewswire Inc.Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
15/07/202422:30GlobeNewswire Inc.Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 InhibitorNASDAQ:ARTLArtelo Biosciences Inc
03/07/202423:00GlobeNewswire Inc.Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
02/07/202423:00GlobeNewswire Inc.Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor PlatformNASDAQ:ARTLArtelo Biosciences Inc
01/07/202423:00GlobeNewswire Inc.Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
04/06/202422:30GlobeNewswire Inc.Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain SocietyNASDAQ:ARTLArtelo Biosciences Inc
29/05/202422:30GlobeNewswire Inc.Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24NASDAQ:ARTLArtelo Biosciences Inc
13/05/202422:00GlobeNewswire Inc.Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
10/05/202423:00GlobeNewswire Inc.Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14thNASDAQ:ARTLArtelo Biosciences Inc
23/04/202422:30GlobeNewswire Inc.Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer TherapyNASDAQ:ARTLArtelo Biosciences Inc
22/04/202422:30GlobeNewswire Inc.Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern TimeNASDAQ:ARTLArtelo Biosciences Inc
25/03/202423:00GlobeNewswire Inc.Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
13/03/202400:15GlobeNewswire Inc.Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation ChallengeNASDAQ:ARTLArtelo Biosciences Inc
24/01/202400:30GlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral NeuropathyNASDAQ:ARTLArtelo Biosciences Inc
09/01/202400:30GlobeNewswire Inc.Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12NASDAQ:ARTLArtelo Biosciences Inc
06/12/202300:30GlobeNewswire Inc.Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
01/12/202301:00GlobeNewswire Inc.Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
14/11/202300:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLArtelo Biosciences Inc
14/11/202300:00GlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
10/11/202301:00GlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain CancersNASDAQ:ARTLArtelo Biosciences Inc
02/11/202323:30GlobeNewswire Inc.Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023NASDAQ:ARTLArtelo Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ARTL